GCTCX
Price
$45.53
Change
-$0.11 (-0.24%)
Updated
Aug 15 closing price
Net Assets
4.21B
VTSAX
Price
$154.04
Change
-$0.41 (-0.27%)
Updated
Aug 15 closing price
Net Assets
1.91T
Interact to see
Advertisement

GCTCX vs VTSAX

Header iconGCTCX vs VTSAX Comparison
Open Charts GCTCX vs VTSAXBanner chart's image
Goldman Sachs US Tax-Managed Eq C
Price$45.53
Change-$0.11 (-0.24%)
VolumeN/A
Net Assets4.21B
Vanguard Total Stock Mkt Idx Adm
Price$154.04
Change-$0.41 (-0.27%)
VolumeN/A
Net Assets1.91T
GCTCX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCTCX vs. VTSAX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCTCX is a Buy and VTSAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.91T vs. GCTCX (4.21B). VTSAX pays higher dividends than GCTCX: VTSAX (1.18) vs GCTCX (0.00). GCTCX was incepted earlier than VTSAX: GCTCX (25 years) vs VTSAX (25 years). GCTCX (1.80) is less costly to investors than VTSAX (0.04). GCTCX is a more actively managed with annual turnover of: 96.00 vs. VTSAX (2.00). GCTCX has a lower initial minimum investment than VTSAX: GCTCX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 16.53 vs. GCTCX (12.66). VTSAX return over 5 years is better than : 86.35 vs. GCTCX (80.11).
GCTCXVTSAXGCTCX / VTSAX
Total Expense Ratio1.760.044,400%
Annual Report Gross Expense Ratio1.800.044,500%
Fund Existence25 years25 years-
Gain YTD7.2379.56676%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets4.21B1.91T0%
Annual Yield % from dividends0.001.18-
Returns for 1 year12.6616.5377%
Returns for 3 years45.1247.2196%
Returns for 5 years80.1186.3593%
Returns for 10 years169.74203.9883%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTGN3.310.36
+12.01%
VistaGen Therapeutics
RXRX5.770.13
+2.30%
Recursion Pharmaceuticals
FTV48.160.36
+0.75%
Fortive Corp
DSS0.83N/A
+0.39%
DSS
CBNK32.68-0.32
-0.97%
Capital Bancorp